Order Article Reprints

Van Steenhoven JEC, Kuijer A, Van Diest PJ, Van Gorp JM, Straver M, Elias SG, Wesseling J, Rutgers E, Timmer-Bonte JNH, Nieboer P, et al. Conventional Pathology Versus Gene Signatures for Assessing Luminal A and B Type Breast Cancers: Results of a Prospective Cohort Study. Genes. 2018; 9(5):261. https://doi.org/10.3390/genes9050261

Van Steenhoven, Julia E.C., Anne Kuijer, Paul J. Van Diest, Joost M. Van Gorp, Marieke Straver, Sjoerd G. Elias, Jelle Wesseling, Emiel Rutgers, Johanna N.H. Timmer-Bonte, Peter Nieboer, and et al. 2018. "Conventional Pathology Versus Gene Signatures for Assessing Luminal A and B Type Breast Cancers: Results of a Prospective Cohort Study" Genes 9, no. 5: 261. https://doi.org/10.3390/genes9050261

Van Steenhoven, J. E. C., Kuijer, A., Van Diest, P. J., Van Gorp, J. M., Straver, M., Elias, S. G., Wesseling, J., Rutgers, E., Timmer-Bonte, J. N. H., Nieboer, P., Smilde, T. J., Imholz, A., Blanken, C. F. J. M., Siesling, S., & Van Dalen, T. (2018). Conventional Pathology Versus Gene Signatures for Assessing Luminal A and B Type Breast Cancers: Results of a Prospective Cohort Study. Genes, 9(5), 261. https://doi.org/10.3390/genes9050261